BACKGROUND: Emerging experimental and clinical data indicates that erythropoietin (EPO) have significant roles in the cardiovascular system. But the relationship between endogenous EPO levels and arterial stiffness remains unknown. We investigated the EPO levels in relation to arterial stiffness parameters in patients with never treated newly diagnosed hypertension (HT). METHODS: We studied 42 (47.8 ± 10 years) never treated HT patients and age and gender-matched 40 (47 ± 8.6 years) normotensive individuals. Serum EPO levels were determined in all subjects using the chemiluminescence immunoassay kit. We evaluated heart rate-corrected augmentation index (AIx@75), a marker of wave reflections and aortic pulse wave velocity (PWV) as indices of elastic-type aortic stiffness using applanation tonometry (Sphygmocor). RESULTS: The levels of EPO were not significantly different in hypertensive patients and the controls (10.6 ± 5 vs. 11.6 ± 9, mIU/mL, p = 0.5). Aortic PWV (10.3 ± 2.3 vs. 8.7 ± 1.6 m/s, p = 0.0001) and AIx@75 (22.7 ± 10 vs. 15 ± 11, %, p = 0.002) were significantly higher in hypertensive patients than the controls. EPO levels were not correlated with brachial and central pressures. Also EPO level was not significantly correlated with AIx@75 (r = -0.15, p = 0.17) and aortic PWV (r = -0.16, p = 0.13). CONCLUSION: Results from this study indicate that endogenous EPO levels may not be a factor in development of increased arterial stiffness.
BACKGROUND: Emerging experimental and clinical data indicates that erythropoietin (EPO) have significant roles in the cardiovascular system. But the relationship between endogenous EPO levels and arterial stiffness remains unknown. We investigated the EPO levels in relation to arterial stiffness parameters in patients with never treated newly diagnosed hypertension (HT). METHODS: We studied 42 (47.8 ± 10 years) never treated HTpatients and age and gender-matched 40 (47 ± 8.6 years) normotensive individuals. Serum EPO levels were determined in all subjects using the chemiluminescence immunoassay kit. We evaluated heart rate-corrected augmentation index (AIx@75), a marker of wave reflections and aortic pulse wave velocity (PWV) as indices of elastic-type aortic stiffness using applanation tonometry (Sphygmocor). RESULTS: The levels of EPO were not significantly different in hypertensivepatients and the controls (10.6 ± 5 vs. 11.6 ± 9, mIU/mL, p = 0.5). Aortic PWV (10.3 ± 2.3 vs. 8.7 ± 1.6 m/s, p = 0.0001) and AIx@75 (22.7 ± 10 vs. 15 ± 11, %, p = 0.002) were significantly higher in hypertensivepatients than the controls. EPO levels were not correlated with brachial and central pressures. Also EPO level was not significantly correlated with AIx@75 (r = -0.15, p = 0.17) and aortic PWV (r = -0.16, p = 0.13). CONCLUSION: Results from this study indicate that endogenous EPO levels may not be a factor in development of increased arterial stiffness.
Authors: Jens Nürnberger; Ayten Keflioglu-Scheiber; Anabelle M Opazo Saez; Rene R Wenzel; Thomas Philipp; Rafael F Schäfers Journal: J Hypertens Date: 2002-12 Impact factor: 4.844
Authors: Stephane Laurent; John Cockcroft; Luc Van Bortel; Pierre Boutouyrie; Cristina Giannattasio; Daniel Hayoz; Bruno Pannier; Charalambos Vlachopoulos; Ian Wilkinson; Harry Struijker-Boudier Journal: Eur Heart J Date: 2006-09-25 Impact factor: 29.983
Authors: Donna M Mancini; Stuart D Katz; Chim C Lang; John LaManca; Alhakam Hudaihed; Ana-Silvia Androne Journal: Circulation Date: 2003-01-21 Impact factor: 29.690
Authors: Nimesh S A Patel; Edward J Sharples; Salvatore Cuzzocrea; Prabal K Chatterjee; Domenico Britti; Muhammad M Yaqoob; Christoph Thiemermann Journal: Kidney Int Date: 2004-09 Impact factor: 10.612
Authors: A Anagnostou; Z Liu; M Steiner; K Chin; E S Lee; N Kessimian; C T Noguchi Journal: Proc Natl Acad Sci U S A Date: 1994-04-26 Impact factor: 11.205
Authors: Marie Briet; Tlili Barhoumi; Muhammad Oneeb Rehman Mian; Cristina Sierra; Pierre Boutouyrie; Michael Davidman; David Bercovitch; Sharon J Nessim; Gershon Frisch; Pierre Paradis; Mark L Lipman; Ernesto L Schiffrin Journal: J Am Heart Assoc Date: 2013-04-12 Impact factor: 5.501